Measurable Residual Disease in ALL: Proof of the Principle Transforming Care for Patients With Hematologic Malignancies

Take advantage of these resources for using MRD as a tool during management of patients with ALL. Watch an expert panel discussion or one of several patient-focused short videos read concise expert commentaries and download the slideset and clinical resource PDF.

Share

Program Content

Activities

MRD in ALL
Measurable Residual Disease in ALL: Proof of the Principle Transforming Care for Patients With Hematologic Malignancies
Congratulations: You achieved a completion on 04/09/2022

No activities added yet

No activities added yet

Activities

MRD in ALL: Resource Guide
At a Glance: Assessing Measurable Residual Disease in Acute Lymphoblastic Leukemia
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 20, 2018

Expires: December 19, 2019

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

Adaptive Biotechnologies

Amgen, Inc.

Partners

GRACE

ProCE Banner